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INTRODUCTION
Cardiospermum halicacabum (倒地鈴 Dào Dì Líng) is a 
creeping perennial plant belonging to the Sapindaceae, widely 
distributed in tropical and subtropical region, especially Tai-
wan, India, and Africa.[1] C. halicacabum is a folk medicine for 
treatment of diuretic, gastroenteritis, rheumatism, lumbago, 
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ABSTRACT
Seventeen compounds, quercetin-3-O-α-l-rhamnoside (1), kaempferol-3-O-α-l-rhamnoside (2), apigenin-7-O-β-d-glucuronide (3), 
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Overhauser Effect spectroscopy (NOESY), as well as comparison with literature values. Furthermore, the High-Performance Liquid 
Chromatography- Photodiode Array Detector (HPLC-DAD) fingerprint profile was established for the determination of major constituents 
in the EtOAc extract and retention times of the isolated compounds. All isolated compounds were also evaluated for antiinflammatory 
and antioxidant activities.
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fever, and nervous diseases. Previous pharmacological stud-
ies in animal model show that the extracts of C. halicacabum 
exhibited antiulcer,[2] analgesic, and vasodepressant activities.[3] 
Phytochemistry studies showed that the title plant contains 
phenolic acid derivatives, flavonol and its glycosides, many 
of which have antiinflammatory and antioxidant activities.[4-6]
In our continuing search for bioactive secondary metabolites 
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from Taiwanese plants, we found that an EtOH extract of C. 
halicacabum showed the inhibition against lipopolysaccharide 
(LPS)-induced nitric oxide (NO) production and antioxidant 
activity by 1,1-Diphenyl-2-picrylhydrazyl (DPPH ) testing. Our 
subsequent phytochemical analysis of the EtOH extract has led 
to the isolation of 10 flavonoids, quercetin-3-O-α-l-rhamnoside 
(1),[7] kaempferol-3-O-α-l-rhamnoside (2),[8] apigenin-7-O-
β-d-glucuronide (3),[9] apigenin 7-O-β-d-glucuronide methyl 
ester (4),[8] apigenin 7-O-β-d-glucuronide ethyl ester (5),[8] 
chrysoeriol (6),[10] apigenin (7),[11] kaempferol (8),[10] luteolin 
(9),[8] quercetin (10)[10] and phenolic acid derivatives, methyl 
3,4-dihydroxybenzoate (11),[12] p-coumaric acid (12),[11] 4-hy-
droxybenzoic acid (13),[13] hydroquinone (14),[14] protocathe-
huic acid (15),[13] gallic acid (16),[13] and indole-3-carboxylic 
acid (17).[15] The structures of all isolated compounds were 
identified by extensive spectroscopic methods including MS 
and 2D-NMR experiments and comparison with the reported 
data. To establish the HPLC-DAD fingerprinting profile of the 
EtOAc extract were described. All isolates were also evaluated 
for antiinflammatory and antioxidant activities.
MATERIALS AND METHODS
General experimental procedures
Optical rotations were measured with JASCO  P-2000 
polarimeter (Japan spectroscopic Co. LTD, Japan ). Infrared 
(IR) and ultraviolet (UV) spectra were measured on a Nicolet 
AVATAR 320 FT-IR spectrophotometer (Nicolet instrument 
corporation, USA) and a U-3310 spectrophotometer (Hitachi 
high-technologies corporation, Japan), respectively. ESIMS 
data were performed on the Waters Quattro Ultima mass 
spectrometer (Waters , USA). 1D and 2D NMR spectra were 
performed on a Bruker NMR spectrometer (Unity Plus 400 
MHz, Bruker corporation, Germany) using CDCl3, CD3OD, 
C5D5N and DMSO-d6 as solvent for measurement. Sephadex 
LH-20 (GE healthcare bio-sciences ABSE-75184 Uppsala, 
Sweden) and silica gel (70–230 mesh and 230–400 mesh, Merck 
LTD., Germany) were used for column chromatography, and 
precoated silica gel 60 F-254 plates (Merck LTD., Germany) 
were used for thin-layer chromatography (TLC). The spots 
on TLC were detected by spraying with 10% H2SO4 and then 
heating on a hot plate. HPLC separations were performed on 
a Shimadzu LC-20A series apparatus (Pump: LC-20AT; UV 
detector: SPD-20A, Shimadzu corporation, Japan), equipped 
with a 250 × 20 mm preparative Cosmosil 5C18-ARII column 
(Nacalai Tesque, INC. Japan). HPLC fingerprint plot was done 
on a Waters 600S separations module (Pump: Waters 600; UV 
detector: Waters 996 Photodiode Array Detector; Controller: 
Waters 600S; Autosampler: Waters 717plus; Degasser: Waters 
In-Line Degasser), with a Cosmosil 5C18-ARII column (5 µm, 
4.6 × 250 mm, Nacalai Tesque, INC. Japan).
Plant material
The dried whole part of Cardiospermum halicabum was 
collected in Taitung, County, Taiwan, in September 2009. A 
voucher specimen (NRICM 20090815A) was identified by 
Dr. Syh-Yuan Hwang and deposited in the National Research 
Institute of Chinese Medicine, Taipei, Taiwan.
Extraction and isolation
The dried whole parts of C. halicabum (12 kg) were ex-
tracted with 95% EtOH (120 L) twice at 50°C, and then ex-
tracted with 70% EtOH (120 L) twice at 50°C. The dark crude 
extracts were combined and concentrated under reduced pres-
sure. The residue was suspended in H2O, and then sequentially 
partitioned with n-hexane, EtOAc, and BuOH, obtained four 
layers. After concentrated under reduced pressure, the EtOAc 
extract (KCHE, 570 g) was fractionated by silica gel column 
(7.5 × 100 cm) eluting with CHCl3/MeOH (100:0, 100:1, 50:1, 
10:1, 5:1, 2:1, 0:100), to yield 12 fractions (Fr. A–L). Fr. C (ca 
30 g) was subjected by Sephadex LH-20 column (7 × 100 cm) 
with CH2Cl2/MeOH (1:1) to yield five subfractions (Fr. C1–C8). 
Fr. C1 (1.7 g) was recrystallized from CH2Cl2 and MeOH to 
give yellow powder, compound 6 (Chrysoeriol, 613 mg). Fr. 
C3 (3.3 g) was repeatedly separated by Sephadex LH-20 (100% 
MeOH, 4.5 × 100 cm) and chromatographed on silica gel using 
a gradient of CH2Cl2/MeOH to obtain compounds 7 (Apigenin, 
527 mg), 14 (Methyl 3,4-dihydroxybenzate, 4 mg), and 15 
(p-Coumaric acid, 80 mg). Fr. C4 (0.7 g) was submitted to 
Sephadex LH-20 column (3 × 135 cm) eluting with MeOH and 
then followed by Reverse Phase-HPLC (RP-HPLC ) (MeOH/
H2O = 65:35) to afford compounds 11 (Hydroquinone, 4 mg), 
12 (4-Hydroxybenzoic acid, 5 mg), and 17 (Indole-3-carboxylic 
acid, 6 mg). The MeOH/CH2Cl2-insoluble portion of Fr. C6 (104 
mg) furnished compound 8 (Kaempferol, 30 mg). Fr. E (ca 17 
g) was subjected on Sephadex LH-20 column (7 × 100 cm) with 
CH2Cl2/MeOH (1:1) to yield seven subfractions (Fr. E1–E7). 
Fr. E3 (2.1 g) was repeatedly chromatographed on Sephadex 
LH-20 column (3 × 135 cm) to yield compounds 9 (Luteolin, 
201 mg), 10 (Quercetin, 128 mg), and 13 (Protocathehuic acid, 
895 mg). Fr. G (ca 27 g) was subjected by Sephadex LH-20 
column (7 × 100 cm) with CH2Cl2/MeOH (1:1) to yield nine 
subfractions (Fr. G1–G9). Fr. G5 (1.6 g) was repeatedly chro-
matographed on Sephadex LH-20 column (4 × 72 cm) to yield 
compound 2 (Kaempferol-3-O-α-l-rhamnoside, 860 mg). Fr. G6 
(1.7 g) was subjected by Sephadex LH-20 column (4 × 120 cm) 
with CH2Cl2/MeOH (1:1) and purified by RP-HPLC (MeCN/
H2O, solvent rate:15-22-26-30-40, flowing time: 5-13-23-28-
30) to afford compounds 4 (apigenin-7-O-β-d-glucuronide 
methyl ester, 105 mg, Rt: 25.4 min) and 5 (apigenin-7-O-β-d-
glucuronide ethyl ester, 126 mg, Rt: 29.4 min). Using the same 
methods as that of Fr. G6 on Sephadex LH-20 (3 × 135 cm), 
compound 16 (35 mg) was obtained from Fr. G7 (0.4 g). Fr. I 
(ca 30 g) was separated by Sephadex LH-20 column (7 × 100 
cm) with CH2Cl2/MeOH to give ten subfractions (Fr. I1–I10). 
Crystallization of Fr. I3 (5.6 g) and I5 (4.3 g), compounds 1 
(Quercetin-3-O-α-l-rhamnoside, 4.3 g) and 3 (apigenin 7-O-β-
d-glucuronide, 3.4 g), were afforded, respectively.
Quercetin-3-O-α-l-rhamnoside (1): Yellow, amorphous 
powder. M.p. 190°C disappeared. α[ ]D25 −141 (c 0.4, MeOH). 
UV (ACN) λmax nm: 222, 254, 348. IR vmax (KBr)/cm−1: 3324, 
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2359, 1659, 1608, 1504, 1364, 1202. For 1H (400 MHz, DMSO-
d6) and 13C (100 MHz) NMR spectroscopic data, see Table 1. 
ESI-MS: m/z 449 [M+H]+.
Kaempferol-3-O-α-l-rhamnoside (2): Yellow, amorphous 
powder. M.p. 180°C disappeared. α[ ]D25 −157 (c 0.4, MeOH). 
UV (ACN) λmax nm: 223, 263, 343. IR vmax (KBr) cm−1: 3357, 
2360, 1658, 1609, 1505, 1361, 1209, 1177, 1087. For 1H (400 
MHz, DMSO-d6) and 13C (100 MHz) NMR spectroscopic data, 
see Table 1. ESI-MS: m/z 455 [M+Na]+.
Apigenin-7-O-β-d-glucuronide (3): Yellow, amorphous 
powder. M.p. 230°C disappeared. α[ ]D25 −40 (c 0.2, MeOH). UV 
(ACN) λmax nm: 222, 266, 336. IR vmax (KBr) cm−1: 3394, 2359, 
1659, 1605, 1497, 1444, 1346, 1246, 1177, 1061. For 1H (400 
MHz, DMSO-d6) and 13C (100 MHz) NMR spectroscopic data, 
see Table 1. ESI-MS: m/z 447 [M+H]+.
Apigenin-7-O-β-d-glucuronide methyl ester (4): White, 
amorphous powder. M.p. 245°C disappeared. α[ ]D25 −55 (c 0.4, 
Acetone). UV (ACN) λmax nm: 222, 266, 336. IR vmax (KBr) cm−1: 
3389, 1742, 1665, 1608, 1499, 1444, 1351, 1301, 1247, 1179, 
1094, 1059. For 1H (400 MHz, DMSO-d6) and 13C (100 MHz) 
NMR spectroscopic data, see Table 1. ESI-MS: m/z 461 [M+H]+.
Apigenin-7-O-β-d-glucuronide ethyl ester (5): White, 
amorphous powder. M.p. 232°C disappeared. α[ ]D25 −98 (c 0.4, 
MeOH). UV (ACN) λmax nm: 222, 266, 337. IR vmax (KBr) cm−1: 
3433, 2073, 1737, 1611, 1502, 1354, 1304, 1247, 1217, 1187, 
1096, 1057, 1016. For 1H (400 MHz, DMSO-d6) and 13C (100 
MHz) NMR spectroscopic data, see Table 1. ESI-MS: m/z 475 
[M+H]+.
Chrysoeriol (6): Yellow, amorphous powder. M.p. >300°C 
disappeared. α[ ]D25 +243 (c 0.2, 50% Acetone). UV (ACN) λmax 
nm: 222, 267, 348. IR vmax (KBr) cm−1: 2348, 2283, 1649, 1624, 
1561, 1502, 1433, 1349, 1270, 1207, 1167, 1028. ESI-MS: m/z 
301 [M+H]+.
Apigenin (7): White, amorphous powder. M.p. >300°C 
disappeared. α[ ]D25 +207 (c 0.2, 50% Acetone). UV (ACN) λmax 
nm: 222, 266, 337. IR vmax (KBr) cm−1: 3444, 2077, 1629, 1502, 
1358, 1246, 1182. ESI-MS: m/z 271 [M+H]+.
Kaempferol (8): Brown, amorphous powder. M.p. 270°C 
disappeared. α[ ]D25 −27 (c 0.4, MeOH). UV (ACN) λmax nm: 223, 
265, 362. IR vmax (KBr) cm−1: 3354, 2283, 1660, 1611, 1510, 
1379, 1258, 1176. ESI-MS: m/z 328 [M+ACN+H]+.
Luteolin (9): Yellow, amorphous powder. M.p. >300°C 
disappeared. α[ ]D25 +49 (c 0.2, MeOH). UV (ACN) λmax nm: 223, 
252, 348. IR vmax (KBr) cm−1: 3422, 2263, 1702, 1656, 1612, 
1504, 1446, 1368, 1266, 1192, 1167, 1121, 1097, 1032. ESI-
MS: m/z 287 [M+H]+.
Quercetin (10): Yellow, amorphous powder. M.p. >300°C 
disappeared. α[ ]D25 +9 (c 0.4, MeOH). UV (ACN) λmax nm: 221, 
254, 365. IR vmax (KBr) cm−1: 3451, 1658, 1519, 1321, 1170, 
1112, 1093, 1011. ESI-MS: m/z 344 [M+H]+.
Hydroquinone (11): White, amorphous powder. M.p. 174°C 
disappeared. UV (ACN) λmax nm: 219, 254. IR vmax (KBr) cm−1: 
3753, 3678, 3652, 3403, 2348, 2282, 1665, 1594, 1509, 1421, 
1315, 1246, 1166. ESI-MS: m/z 193 [M+2ACN+H]+.
4-hydroxybenzoic acid (12): White, amorphous powder. 
M.p. 150°C disappeared. α[ ]D25 7 (c 0.4, MeOH). UV (ACN) 
λmax nm: 219, 254. IR vmax (KBr) cm−1: 3753, 3678, 3652, 3403, 
2348, 2282, 1665, 1594, 1509, 1421, 1315, 1246, 1166. ESI-
Table 1. 1H- and 13C-NMR spectroscopic data of compounds 1 and 2
No. Compound 1 (Pyridine-d6) Compound 2 (MeOH-d4)
δH (mult, J in Hz)b δC (mult)c δH (mult, J in Hz)b δC (mult)c
2 158.1 (s) 159.1 (s)
3 135.9 (s) 136.1 (s)
4 179.0 (s) 179.5 (s)
5 162.8 (s) 163.3 (s)
6 6.67 (d, 2.0) 99.6 (d) 6.16 (d, 2.0) 100.1 (d)
7 165.7 (s) 166.7 (s)
8 6.62 (d, 2.0) 94.4 (d) 6.33 (d, 2.0) 94.9 (d)
9 157.6 (s) 158.5 (s)
10 105.3 (s) 105.6 (s)
1' 122.2 (s) 122.6 (s)
2' 8.00 (d, 2.4) 117.0 (d) 7.74 (d, 8.8) 131.9 (s)
3' 147.2 (s) 6.91 (d, 8.8) 116.5 (d)
4' 150.4 (s) 161.5 (s)
5' 7.67 (dd, 8.4, 2.0) 116.4 (d) 6.91 (d, 8.8) 116.5 (d)
6' 7.28 (d, 8.4) 122.2 (d) 7.74 (d, 8.8) 131.9 (d)
Sugar moiety
1'' 6.24 (br s) 103.9 (d) 5.36 (d, 1.2) 103.5 (d)
2'' 5.06 (dd, 3.2, 1.6) 71.9 (d) 4.22 (dd, 3.2, 1.6) 71.9 (d)
3'' 4.63 (dd, 8.8, 3.2) 72.4 (d) 4.70 (dd, 6.0, 3.2) 72.1 (d)
4'' 4.28 (m) 73.2 (d) 3.33 (m) 73.2 (d)
5'' 4.38 (m) 72.0 (d) 3.32 (m) 72.0 (d)
6'' 1.45 (d, 6.0) 18.3 (q) 0.91 (d, 5.2) 17.6 (q)
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MS: m/z 137 [M−H]−.
Protocathehuic acid (13): Brown, amorphous powder. 
M.p. 185°C disappeared. α[ ]D25 +3 (c 0.4, MeOH). UV (ACN) 
λmax nm: 221, 259, 293. IR vmax (KBr) cm−1: 3856, 3692, 3678, 
3651, 3631, 3589, 3569, 3358, 2348, 2283, 2078, 1891, 1686, 
1655, 1618, 1535, 1460, 1439, 1025. ESI-MS: m/z 153 [M−H]−.
Methyl 3,4-dihydroxybenzoate (14): Brown, amorphous 
powder. M.p. 140°C disappeared. α[ ]D25 +143 (c 0.2, 50% Ac-
etone). UV (ACN) λmax nm: 221, 260, 292. IR vmax (KBr) cm−1: 
3485, 2282, 1677, 1597, 1523, 1434, 1280, 1239, 1204, 1028. 
ESI-MS: m/z 199 [M+MeOH−H]−.
Gallic acid (15): White, amorphous powder. M.p. 250°C 
disappeared. α[ ]D25 +3 (c 0.4, MeOH). UV (ACN) λmax nm: 221, 
270. IR vmax (KBr) cm−1: 3856, 3753, 3738, 3475, 2095, 1630, 
1524, 1449, 1341, 1310, 1261, 1200, 1107, 1035. ESI-MS: 
m/z 169 [M−H]−.
p-Coumaric acid (16): White, amorphous powder. M.p. 
280°C disappeared. α[ ]D25 −7 (c 0.4, MeOH). UV (ACN) λmax nm: 
226, 360. IR vmax (KBr) cm−1: 3652, 3398, 2282, 1676, 1604, 
1512, 1450, 1312, 1251, 1173. ESI-MS: m/z 163 [M − H]−.
Indole-3-carboxylic acid (17): Yellow, amorphous powder. 
M.p. 210°C disappeared. α[ ]D25 +60 (c 0.2, MeOH). UV (ACN) 
λmax nm: 226, 280. IR vmax (KBr) cm−1: 3651, 2934, 2348, 2247, 
1691, 1421, 1308, 1200. ESI-MS: m/z 162 [M+H]+.
HPLC fingerprint assay
Materials and Reagents: Seventeen reference compounds 
(1–17) isolated from the EtOAc extract (KCHE) of C. hali-
cacabum. Acetonitrile (LC grade) were purchased from E. 
Merck. Milli-Q ultra-pure water (Millipore, Q-gard 1/Quantum 
EX) was used throughout the study. Apparatus and conditions: 
The HPLC was performed on a Waters system equipped with 
a Waters 600S controller, a Waters 600 pump, a photodiode 
array detector (Waters 996), a Waters In-line degasser, and 
Waters 717plus autosampler. The Cosmosil 5C18-AR-II (5 
µm, 4.6 × 250 mm) eluted at a rate of 0.8 mL/min. The mobile 
phase consisted of water (A) and acetonitrile (B), together 
with 1% tri-fluoroacetic acid TFA , using a gradient program 
of 5%-25%-25%-30% (B) in 0-10-30-60 min. DAD detector 
was set at 254 nm for acquiring chromatograms, UV spectra 
and 3D-plots were recorded between 200 and 400 nm. Prepa-
ration of standard solutions, each compound was accurately 
weighed and dissolved in MeOH, the terminate concentration 
was ca. 100 µg/mL. Preparation of sample solution, the KCHE 
extract from C. halicacabum was dried under vacuum, then 10 
mg was weighed accurately and dissolved in MeOH (1 mL). 
All the tested solutions were filtered through a 0.45 µm filter 
(Millipore) before use.
Scavenging activity of DPPH radical assay 
The radical scavenging activity of the isolates on DPPH free 
radical was measured using the method of Chung et al.[16] with 
minor modifications. The aliquot of each sample (120 μL, 30–5 
μg/mL), or (±)-α-tocopherol (40–10 μg/mL) was mixed with 30 
μL of 0.75 mM DPPH methanol solution in 96-well microplate. 
The mixture was shaken vigorously with orbital shaker in the 
dark at room temperature for 30 min and then measured the 
absorbance at 517 nm with enzyme-linked immunosorbent as-
say (ELISA ) reader. The negative control was the measurement 
using methanol to replace the sample in the react solution. The 
DPPH radical scavenging activity of the isolates were compared 
with the negative control and positive control (±)-α-tocopherol. 
The final results were performed as the concentrations of ED50, 
which is the concentration of sample required to cause 50% 
inhibition against DPPH radicals in react solution.
NO Measurement of antiinflammatory activity 
The macrophage cell line RAW 264.7 was obtained from 
ATCC (Rockville, MD, U.S.A.) and cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) containing 5% heat-
inactivated fetal calf serum, 100 U/mL penicillin and strepto-
mycin, respectively, and grown at 37°C with 5% CO2 in fully 
humidified air. Cells were plated at a density of 5 × 104 cells/
well in 96-well culture plate and stimulated with LPS (1.0 μg/
mL) in the presence or absence of different concentrations of 
tested compounds (0.1–40 μM) for 24 h simultaneously. All 
compounds were dissolved in dimethyl sulfoxide (DMSO) and 
further diluted with sterile phosphate buffered saline (PBS). 
Nitrite (NO2-) accumulation in the medium was used as an 
indicator of NO production, which was measured by adding 
Griess reagent (1% sulfanilamide in H2O and 0.1% naphthyl-
enediamine in 5% phosphoric acid). NaNO2 was used to gen-
erate a standard curve, and nitrite production was determined 
by measuring optical density at 540 nm. All experiments were 
performed in triplicate. NO production by LPS stimulation was 
designated as 100% for each experiment. Quercetin was as a 
positive control.
RESULTS AND DISCUSSION
The EtOH extract of the whole parts of C. halicacabum 
was suspended in H2O and further successively partitioned 
with n-hexane, EtOAc, and BuOH. After evaporation of the 
each solvent, the EtOAc extract exhibited potent antiinflam-
matory activity by NO production testing (IC50 = 32.12 µg/mL) 
and antioxidant activity against free radicals (DPPH) (ED50 = 
28.97 µg/mL). The EtOAc residue was subjected to column 
chromatography on silica gel and Sephadex LH-20, and HPLC 
to yield 17 compounds, including 10 flavanoids and 7 phenolic 
acids derivatives. All isolated compounds were identified by 
detailed spectroscopic analyses, especially Mass spectroscopy 
(MS) and 2D NMR experiments, comparing those of authentic 
samples and references. Their structures are shown in Figure 1. 
We further established the HPLC-DAD fingerprinting profile 
of the EtOAc extract of which 17 main peaks were identified.
Compound 1 was obtained as yellow amorphous powder 
with molecular formula C21H21O11, as established by positive 
ESIMS, in combination with NMR spectroscopic data. IR ab-
sorptions at 3324, 1659, 1608, and 1504 cm−1 and UV data at 
254 and 348 nm implied the existence of hydroxyl, conjugated 
carbonyl groups, and aromatic ring, respectively. In the 1H NMR 
spectrum [Table 1], five aromatic proton signals at δH 6.67 (H-6, 
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d, J = 2.0 Hz), 6.62 (H-8, d, J = 2.0 Hz), 7.28 (H-5′, d, J = 8.4 
Hz), 7.67 (H-6′, dd, J = 8.4, 1.6 Hz), and 8.00 (H-2′, d, J = 1.6 
Hz), and proton resonances for sugar moiety at 5.06 (H-1′′, d, 
J = 6.8 Hz), 4.63 (H-2′′, dd, J = 8.8, 3.2 Hz), 4.63 (H-3′′, m), 
4.28 (H-4′′, m), 4.38 (H-5′′, m), and 1.45 (H-6′′, d, J = 6.0 Hz) 
were observed. The 13C NMR spectra showed resonance for 
21 carbons differentiated by the distortionless enhancement 
by polarization transfer (DEPT)  experiments, including one 
carbonyl (C-4, δC 179.0), five aromatic methines (δC 99.6, C-6; 
94.4, C-8; 117.0, C-2′; 116.4, C-5′; 122.2, C-6′), nine quaternary 
aromatic signals (δC 158.1, C-2; 135.9, C-3; 162.8, C-5; 165.7, 
C-7; 157.6, C-9; 105.3, C-10; 122.2, C-1′; 147.2, C-3′; 150.4, 
C-4′), and five oxygenated methines (δC 103.9, 73.2, 72.4, 72.0, 
71.9) and methyl (δC 18.3). Those data indicated compound 1 
as having a basic flavonol structure with rhamnose moiety. The 
planar structure and NMR assignments for 1 were established by 
detailed analysis of two-dimensional NMR (2D NMR), includ-
ing 1H-1H COSY, HMQC, and HMBC correlations [Figure 2]. 
The 1H-1H COSY spectra, coupling with HMQC, allowed 
the establishment of two spin systems, corresponding to two 
structural fragments of C-5′/C-6′ and C-1′′/C-2′′/C-3′′/C-4′′/C-
5′′/C-6′′. The HMBC correlations of H-2′/C-2, C-1′, C-3′, and 
C-4′, H-5′/C-2, C-1′, and H-5′/C-3′ and C-4′ indicated 3′,4′-di-
hydroxy substitution of aromatic ring located at C-2. Acid 
hydrolysis of compound 1 gave an aglycone, quercetin (10) 
and a sugar moiety, the latter was identified by HPLC analysis 
as L-rhamnose. Furthermore, HMBC spectrum of 1 indicated 
the bonding position of L-rhamnose to be C-3 according to the 
correlations of H-1′′/C-3. The α-anomeric configuration for the 
rhamnose was judged by the coupling constant. On the basis of 
the above spectroscopic evidence, compound 1 was deduced 
as quercetin-3-O-α-l-rhamnoside.
Compound 2 was obtained as a yellow amorphous powder. 
ESIMS (positive) showed a quasi-molecular ion peak at m/z 
455 [M+Na]+, corresponding to the formula C21H20O10, and 
agreed with its 1H and 13C NMR data. Similar to 1, compound 
2 showed IR bands at 3357, 1658, 1609, and 1505 cm−1 and 
UV absorptions at 223, 263, and 343 nm, indicating conjugated 
carbonyl groups, and aromatic ring, respectively. It was found 
that the 13C-NMR spectroscopic data [Table 1] of compound 
2 were closely related to those of 1. However, detailed cross 
comparison of 1H-NMR spectroscopic data showed that the 
ABX signals in compound 1 were replaced by A2B2 pattern 
system (δH 7.74, d, J = 8.8 Hz, 2H; 6.91, d, J = 8.8 Hz; δC 131.9 
× 2, 116.5 × 2) in 2. This was in accordance with the molecular 
formula of 1, which contained one more oxygen atom than that 
of 2. The complete structure of 2 was further supported by 
detailed anaylsis of 1H-1H COSY, HSQC, and HMBC spectra 
data. According to the above observation, compound 2 was 
determined as kaempferol-3-O-α-l-rhamnoside.
Compound 3 was obtained as yellow amorphous powder, 
Mp. 230°C, with molecular formula C21H18O11, as determined 
by ESIMS and its NMR data. The UV data, with absorption 
maxima at λmax 222, 266, 336 nm, and IR absorption bands at-
tributable to hydroxyl (3394 cm−1), conjugated carbonyl (1659 
cm−1), aromatic (1605 and 1497 cm−1) functionalities, suggested 
the presence of flavanoid skeleton. The 1H NMR spectrum 
of compound 3 [Table 2] showed a pair of doublet aromatic 
proton signals at δH 6.44 (H-6, d, J = 2.0 Hz) and 6.76 (H-8, d, 
J = 1.6 Hz) and A2B2-type aromatic proton signals at δH 7.80 
(H-2′, H-6′, d, J = 8.4 Hz, 2H) and 6.88 (H-3′, H-5′, d, J = 8.4 
Hz, 2H). The evidences was suggested that the aglycone was 
a 4’,5,7-trihydroxyflavone (also called apigenin). In addition, 
the 1H and 13C NMR spectra also indicated the presence of a 
glucuronic acid moiety from the following signals [δH 3.98, 
d, J = 8.4 Hz; δC 174.4], which are the characteristics for the 
H-5′′ and C-6′′ of the sugar moiety, respectively. The HMBC 
correlations between H-1′′ (δH 5.12)/C-7 (δC 164.6) suggested 
that the sugar located at C-7 positions. The sugar moiety was 
further confirmed to be β-glucose on the basis of coupling con-
stant (J = 6.8 Hz) of anomeric proton in the 1H-NMR spectrum 
of 3 and the D-form was identified by acid hydrolysis with an 
authentic sample. From the above corroboration, compound 3 
was defined as apigenin-7-O-β-d-glucuronide. 
Compound 4, obtained as a yellow solid, was assigned the 
molecular formula C22H20O11, as determined form ESIMS, 13C 
NMR, and DEPT spectroscopic data. The 1H and 13C NMR 
spectra showed resonance characteristics of flavonol skeleton 
with a hexose moiety, similar to those of compound 3. How-
ever, in the 1H and 13C NMR spectra, an additional oxygenated 
methyl group at δH 3.62 and δC 52.0 was observed, which was 
Figure 1. The structures of compounds 1–17 isolated from C. halicacabum
Figure 2. The key HMBC and 1H-1H COSY correlations of compounds 
1 and 3-5
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correlated to C-6′′ (δC 170.1) in the HMBC spectrum, indicat-
ing that methyl group located at C-6′′ of the sugar moiety. 
Consequently, the structure of 4 was determined to be apigenin 
3-O-β-d-glucuronide methyl ester.
The molecular formula of compound 5 was determined to 
be C23H22O11 from the analysis of its ESIMS and NMR spec-
troscopic data. Due to the similar IR, UV, and 1H and 13C NMR 
spectra as those of compounds 3 and 4, the basic skeleton of 
5 was comprised of a flavonol and a glucuronic acid moiety, 
except for the additional presence of a ethyl signal (δH 4.15, m; 
1.07, t, J = 7.2 Hz; δC 61.3, 13.9) in 5. The HMBC correlations 
of H-1′′′ and H-2′′′ with C-6′′ (δC 169.6) as well as the COSY 
correlation of H-1′′′/H-2′′′ indicated that the methyl group at 
C-6 in 4 was replaced by the ethyl group in compound 5. The 
assignments of 1H and 13C NMR data of compound 5 were 
accomplished by 1H-1H COSY, HMQC, and HMBC correla-
tions. Therefore, compound 5 was unambiguously identified 
as apigenin 7-O-β-d-glucuronide ethyl ester.
The UV and NMR spectroscopic features of the other flavo-
nols, chrysoeriol (6), apigenin (7), kaempferol (8), luteolin (9), 
quercetin (10), were very similar to one another, suggesting that 
they were flavonoids, similar to compounds 1–5. The UV spectra 
of flavonols 1–10 are illustrated in Figure 3. Compounds 6–10 
also were identified by analyses of NMR spectroscopic data and 
comparison with data reported in the literature. In addition, seven 
phenolic acids derivatives were isolated from the EtAOc extract 
of C. halicacabum, and 3,4-dihydroxybenzoate (11), p-coumaric 
acid (12), 4-hydroxybenzoic acid (13), hydroquinone (14), pro-
tocathehuic acid (15), gallic acid (16), indole-3-carboxylic acid 
(17), determined based on the spectroscopic analysis.
We have studied the fingerprinting profile [Figure 4] of the 
bioactive EtOAc extract of C. halicacabum by using HPLC-
DAD method. The mobile phase consisted of water (A) and 
acetonitrile (B) with 1% TFA, using a gradient program of 
5%-25%-25%-30% (B) in 0-10-30-60 min. These isolated 
flavonoids and phenolic acids were detected at 280 nm and 
identified by matching the retention time (Rt) with responding 
compounds and their UV spectroscopic characteristics. The 17 
Rts for the isolated compounds 1–17 were, respectively, shown 
as 1: 22.79; 2: 25.96; 3: 24.04; 4: 32.85; 5: 43.51; 6: 57.56; 7: 
53.69; 8: 55.94; 9 & 10: 35.87; 11: 7.30; 12: 16.34; 13: 11.44; 
14: 18.03; 15: 6.04; 16: 21.02; 17: 24.55 min. The major com-
ponents existed in the EtOAc extract were almost identified. 
Moreover, all of the isolated compounds were tested for 
antiinflammatory activity by the inhibition effects on the 
LPS-induced NO production in RAW 264.7 macrophages. 
As summarized in Table 3, compounds 3–5, 7, 8, 12, 16, and 
17 showed potent inhibitory activities against NO production 
and did not affect cell viability. Among them, phenolic acids 
derivatives 12 (IC50 = 2.64 µg/mL) and 16 (IC50 = 1.66 µg/
mL) exhibited more potent than flavonoids. In addition, these 
isolated compounds also were tested for antioxidant activities 
by using the stable DPPH method. As shown in Table 4, com-
pounds 1, 8, 9, 10, 15, and 16 had potent antioxidant activities; 
Table 2. 1H- and 13C-NMR spectroscopic data of compounds 3-5
No. Compound 3 (DMSO-d6) Compound 4 (Pyridine-d5) Compound 5 (Pyridine-d5)
δH (mult, J in Hz)b δC (mult)c δH (mult, J in Hz)b δC (mult)c δH (mult, J in Hz)b δC (mult)c
2 166.6 (s) 163.5 (s) 163.4 (s)
3 6.58 (s) 104.0 (d) 6.87 (s) 103.8 (d) 6.86 (s) 103.8 (d)
4 184.0 (s) 182.6 (s) 182.6 (s)
5 162.7 (s) 162.5 (s) 162.5 (s)
6 6.44 (d, 2.0) 101.2 (d) 6.84 (d, 2.0) 100.4 (d) 6.82 (br s) 100.4 (d)
7 164.6 (s) 164.8 (s) 164.8 (s)
8 6.76 (d, 1.6) 96.0 (d) 7.11 (br s) 95.2 (d) 7.11 (br s) 95.2 (d)
9 158.9 (s) 157.7 (s) 157.7 (s)
10 107.1 (s) 106.6 (s) 106.6 (s)
1' 122.9 (s) 121.8 (s) 121.7 (s)
2' 7.80 (d, 8.8) 129.6 (d) 7.80 (d, 8.4) 128.8 (d) 7.80 (d, 8.4) 128.8 (d)
3' 6.88 (d, 8.8) 117.0 (d) 7.18 (d, 8.4) 116.7 (d) 7.18 (d, 8.4) 116.7 (d)
4' 162.8 (s) 162.7 (s) 162.7 (s)
5' 6.88 d (d, 8.8) 117.0 (d) 7.18 (d, 8.4) 116.7 (d) 7.18 (d, 8.4) 116.7 (d)
6' 7.80 d (d, 8.8) 129.6 (d) 7.80 (d, 8.4) 128.8 (d) 7.80 (d, 8.4) 128.8 (d)
Sugar moiety
1'' 5.12 (d, 6.8) 101.4 (d) 6.00 (d, 7.2) 101.5 (d) 6.00 (d, 6.4) 101.5 (d)
2'' 3.55 (m) 74.5 (d) 4.91 (d, 9.6) 74.3 (d) 4.87 (d, 9.6) 74.3 (d)
3'' 3.55 (m) 76.5 (d) 4.58 (dd, 9.6, 8.8) 77.1 (d) 4.60 (dd, 9.2, 8.8) 77.2 (d)
4'' 3.55 (m) 73.2 (d) 3.44 (m) 72.5 (d) 3.46 (m) 72.7 (d)
5'' 3.98 (d, 9.2) 77.4 (d) 3.41 (m) 77.4 (d) 3.42 (m) 77.4 (d)
6'' 174.4 (s) 170.1 (s) 169.6 (s)
1''' 3.62 (s) 52.0 (q) 4.15 (m) 61.3 (t)
2'' 1.07 (t, 7.2) 13.9 (q)
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Figure 4. The HPLC-DAD profile of EtOAc extract and reference 
compounds of C. halicacabum
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